Treatment of three pediatric AML co-expressing NUP98-NSD1, FLT3-ITD, and WT1
Abstract During the treatment of 89 pediatric patients with Acute Myeloid Leukemia (AML) at the Hematology Department of Kunming Medical University's Children's Hospital from 2020 to 2023, three patients were identified to co-express the NUP98-NSD1, FLT3-ITD, and WT1 gene mutations. The bo...
Saved in:
Main Authors: | Li Liu (Author), Qi Nie (Author), Zugang Xiao (Author), Xin Chen (Author), Chunhui Yang (Author), Xiaoyan Mao (Author), Na Li (Author), Yan Zhou (Author), Qulian Guo (Author), Xin Tian (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NUP98::NSD1 and FLT3/ITD co-expression is an independent predictor of poor prognosis in pediatric AML patients
by: Jing-wen Wang, et al.
Published: (2024) -
Leukoreductive response to the combination of sorafenib and chemotherapy in hyperleukocytosis of FLT3-ITD mutated pediatric AML
by: Franziska Schmidt, et al.
Published: (2022) -
Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy Efficacy
by: Sankaranarayan Kannan, et al.
Published: (2022) -
Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3‐ITD AML
by: Daelynn R. Buelow, et al.
Published: (2019) -
Novel combined variants of WT1 and TET2 in a refractory and recurrent AML patient
by: Qiang Ma, et al.
Published: (2021)